Smith & Nephew (SNN) Liabilities and Shareholders Equity (2009 - 2025)
Smith & Nephew (SNN) reported Liabilities and Shareholders Equity of $10.5 billion for Q4 2025, up 0.99% on a YoY basis from $10.4 billion in Q4 2024, and down 2.2% quarter-over-quarter from $10.7 billion in Q2 2025.
Smith & Nephew (SNN) Liabilities and Shareholders Equity (2009 - 2025) Analysis & Trends
Smith & Nephew has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $10.5 billion in Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 0.99% year-over-year to $10.5 billion; the trailing twelve-month figure through Dec 2025 stood at $42.0 billion (up 100.96% YoY), and the FY2025 full-year result was $10.5 billion, up 0.99% from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $10.5 billion, down from $10.7 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $10.7 billion in Q2 2025, with the low at $8.0 million in Q4 2023.
- Historically, Liabilities and Shareholders Equity has averaged $6.0 billion across 5 years, with a median of $10.4 billion in 2024.
- Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity sank 55.56% — and 2024, when it jumped 129325.0%.
- Smith & Nephew's Liabilities and Shareholders Equity stood at $10.0 million in 2021, then soared by 80.0% to $18.0 million in 2022, then slumped by 55.56% to $8.0 million in 2023, then jumped by 129325.0% to $10.4 billion in 2024, then gained by 0.99% to $10.5 billion in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $10.5 billion (Q4 2025), $10.7 billion (Q2 2025), and $10.4 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - | 10.46 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.46 Bn |
| Jun 28, 2025 | 10.69 Bn |
| Dec 31, 2024 | 10.35 Bn |
| Jun 29, 2024 | 10.54 Bn |
| Dec 31, 2023 | 8.00 Mn |
| Dec 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 10.00 Mn |
| Dec 31, 2020 | 9.00 Mn |
| Jun 30, 2020 | 9.54 Bn |
| Dec 31, 2019 | 7.00 Mn |
| Jun 29, 2019 | 8.95 Bn |
| Dec 31, 2018 | 34.00 Mn |
| Jun 30, 2018 | 7.71 Bn |
| Dec 31, 2017 | 21.00 Mn |
| Dec 31, 2016 | 7.34 Bn |
| Dec 31, 2015 | 7.17 Bn |
| Jun 30, 2015 | 7.22 Bn |
| Dec 31, 2014 | 7.31 Bn |
| Sep 30, 2014 | 7.65 Bn |
| Jun 28, 2014 | 7.74 Bn |